Rigel Pharmaceuticals (RIGL) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 405.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 405.15% |
| Dec 31, 2025 | 51.91% |
| Sep 30, 2025 | 10.85% |
| Jun 30, 2025 | 10,011.59% |
| Mar 31, 2025 | 82.19% |
| Dec 31, 2024 | 332.00% |
| Sep 30, 2024 | 1,695.22% |
| Jun 30, 2024 | -94.91% |
| Mar 31, 2024 | -23.05% |
| Dec 31, 2023 | 71.61% |
| Sep 30, 2023 | 89.93% |
| Jun 30, 2023 | 146.06% |
| Mar 31, 2023 | 84.25% |
| Dec 31, 2022 | -15.30% |
| Sep 30, 2022 | -28.88% |
| Jun 30, 2022 | -123.49% |
| Mar 31, 2022 | -29.14% |
| Dec 31, 2021 | -18.59% |
| Sep 30, 2021 | 46.81% |
| Jun 30, 2021 | 491.66% |
| Mar 31, 2021 | -441.24% |
| Dec 31, 2020 | -56.69% |
| Sep 30, 2020 | -31.24% |
| Jun 30, 2020 | 16.53% |
| Mar 31, 2020 | -291.12% |
| Dec 31, 2019 | -188.64% |
| Sep 30, 2019 | 25.92% |
| Jun 30, 2019 | 39.42% |
| Mar 31, 2019 | 95.99% |
| Dec 31, 2018 | 158.55% |
| Sep 30, 2018 | -14.56% |
| Jun 30, 2018 | -42.06% |
| Mar 31, 2018 | -13.40% |
| Dec 31, 2017 | -58.52% |
| Sep 30, 2017 | 22.60% |
| Jun 30, 2017 | -4.42% |
| Mar 31, 2017 | 8.52% |
| Dec 31, 2016 | 10.49% |
| Sep 30, 2016 | -133.75% |
| Jun 30, 2016 | -2.42% |
| Mar 31, 2016 | -226.66% |
| Dec 31, 2015 | 8.37% |
| Sep 30, 2015 | 46.75% |
| Jun 30, 2015 | 8.99% |
| Mar 31, 2015 | 208.12% |
| Dec 31, 2014 | 20.27% |
| Sep 30, 2014 | 12.14% |
| Jun 30, 2014 | 7.19% |
| Mar 31, 2014 | 35.60% |
| Dec 31, 2013 | 13.99% |
| Sep 30, 2013 | -4.31% |
| Jun 30, 2013 | -0.06% |
| Mar 31, 2013 | -3.78% |
| Dec 31, 2012 | -17.69% |
| Sep 30, 2012 | -49.84% |
| Jun 30, 2012 | -20.69% |
| Mar 31, 2012 | -14.91% |
| Dec 31, 2011 | -301.70% |
| Sep 30, 2011 | 32.91% |